Efficacy and safety of maralixibat treatment in patients with Alagille syndrome and cholestatic pruritus (ICONIC): a randomised phase 2 study

DSpace Repository

Efficacy and safety of maralixibat treatment in patients with Alagille syndrome and cholestatic pruritus (ICONIC): a randomised phase 2 study

Author: Gonzales, Emmanuel; Hardikar, Winita; Stormon, Michael; Baker, Alastair; Hierro, Loreto; Gliwicz, Dorota; Lacaille, Florence; Lachaux, Alain; Sturm, Ekkehard; Setchell, Kenneth D. R.; Kennedy, Ciara; Dorenbaum, Alejandro; Steinmetz, Jana; Desai, Nirav K.; Wardle, Andrew J.; Garner, Will; Vig, Pamela; Jaecklin, Thomas; Sokal, Etienne M.; Jacquemin, Emmanuel
Tübinger Autor(en):
Sturm, Ekkehard
Published in: Lancet (2021), Bd. 398, H. 10311, S. 1581-1592
Verlagsangabe: New York
Language: English
Full text: https://doi.org/10.1016/S0140-6736(21)01256-3
ISSN: 0140-6736
DDC Classifikation: 610 - Medicine and health
Dokumentart: Article
Show full item record

This item appears in the following Collection(s)